Literature DB >> 14622094

Inhibition of excitatory neuronal cell death by cell-permeable calcineurin autoinhibitory peptide.

Hiroaki Terada1, Masayuki Matsushita, Yun-Fei Lu, Takeshi Shirai, Sheng-Tian Li, Kazuhito Tomizawa, Akiyoshi Moriwaki, Shinsaku Nishio, Isao Date, Takashi Ohmoto, Hideki Matsui.   

Abstract

In glutamate-mediated excitatory neuronal cell death, immunosuppressants (FK506, Cys-A) are powerful agents that protect neurons from apoptosis. Immunosuppressants inhibit two types of enzyme, calcium/calmodulin-dependent protein phosphatase (calcineurin: CaN), and peptidyl-prolyl cis-trans-isomerase (PPIase) activity such as the FKBP family. In this study, we used a protein transduction approach to determine the functional role of CaN and to produce a potential therapeutic agent for glutamate-mediated neuronal cell death. We created a novel cell-permeable CaN autoinhibitory peptide using the 11 arginine protein transduction domain. This peptide was highly efficient at transducing into primary culture neurons, potently inhibited CaN phosphatase activities, and inhibited glutamate-mediated neuronal cell death. These results showed that CaN plays an important role in excitatory neuronal cell death and cell-permeable CaN autoinhibitory peptide could be a new drug to protect neurons from excitatory neuronal death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622094     DOI: 10.1046/j.1471-4159.2003.02098.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

Review 1.  Protein transduction technology.

Authors:  Masayuki Matsushita; Hideki Matsui
Journal:  J Mol Med (Berl)       Date:  2005-02-10       Impact factor: 4.599

2.  Phosphorylation-dependent low-frequency depression at phasic synapses of a crayfish motoneuron.

Authors:  Lorelei B Silverman-Gavrila; Peter M R Orth; Milton P Charlton
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

3.  Calcineurin activity is required for the completion of cytokinesis.

Authors:  Megan Chircop; Chandra S Malladi; Audrey T Lian; Scott L Page; Michael Zavortink; Christopher P Gordon; Adam McCluskey; Phillip J Robinson
Journal:  Cell Mol Life Sci       Date:  2010-05-23       Impact factor: 9.261

4.  PP2B-dependent NO production in the medullary thick ascending limb during diabetes.

Authors:  Jan M Foster; Pamela K Carmines; Jennifer S Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-20

5.  Activity-dependent fusion pore expansion regulated by a calcineurin-dependent dynamin-syndapin pathway in mouse adrenal chromaffin cells.

Authors:  Prattana Samasilp; Shyue-An Chan; Corey Smith
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

6.  Protein phosphatase 2B inhibition promotes the secretion of von Willebrand factor from endothelial cells.

Authors:  L H Nolasco; F C Gushiken; N A Turner; T S Khatlani; S Pradhan; J-F Dong; J L Moake; K V Vijayan
Journal:  J Thromb Haemost       Date:  2009-03-27       Impact factor: 5.824

7.  The serine-threonine phosphatase calcineurin is a regulator of endothelial store-operated calcium entry.

Authors:  Audrey A Vasauskas; Hairu Chen; Songwei Wu; Donna L Cioffi
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

8.  Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.

Authors:  Maaike Kockx; Dongni Lily Guo; Mathew Traini; Katharina Gaus; Jason Kay; Sabine Wimmer-Kleikamp; Carles Rentero; John R Burnett; Wilfried Le Goff; Miranda Van Eck; Jennifer L Stow; Wendy Jessup; Leonard Kritharides
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

9.  Calcineurin-mediated dephosphorylation of eNOS at serine 116 affects eNOS enzymatic activity indirectly by facilitating c-Src binding and tyrosine 83 phosphorylation.

Authors:  Ling Ruan; Christina M Torres; Ryan J Buffett; Simone Kennard; David Fulton; Richard C Venema
Journal:  Vascul Pharmacol       Date:  2013-05-30       Impact factor: 5.773

10.  Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?

Authors:  Matthias Sieber; Ria Baumgrass
Journal:  Cell Commun Signal       Date:  2009-10-27       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.